Meta-analysis of fenestrating versus reconstituting subtotal cholecystectomy in the management of difficult gallbladder
HPB · 2024-01 · 26 (1) · 8-20
DOI: 10.1016/j.hpb.2023.09.005 ↗Kurz gefasst
Metaanalyse in der Zeitschrift HPB, 2024-01. Verfasst von Shahin Hajibandeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent…. Hauptthemen laut MEDLINE: Cholecystectomy, Laparoscopic, Cholecystitis, Laparoscopy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
AIMS: To evaluate comparative outcomes of fenestrating and reconstituting subtotal cholecystectomy (STC) in patients with difficult gallbladder. METHODS: A systematic search of electronic data sources and bibliographic reference lists were conducted. All comparative studies reporting outcomes of laparoscopic fenestrating and reconstituting STC were included and their risk of bias were assessed using ROBINS-I tool. RESULTS: Seven comparative studies were included enrolling 590 patients undergoing laparoscopic STC using either fenestrating (n = 353) or reconstituting (n = 237) approaches. Although fenestrating STC was associated with a significantly higher rate of bile leak (OR: 2.47, p = 0.007) compared to reconstituting STC, both approaches were comparable in terms of resolution of bile leak without (RD: -0.02, p = 0.86) or with (OR: 1.84, p = 0.40) postoperative ERCP. Moreover, there was no significant difference in development of bile duct injury (RD: -0.02, p = 0.16), need for postoperative ERCP (OR: 1.36, p = 0.49), wound infection (RD: 0.03, p = 0.27), re-operation (OR: 0.95, p = 0.95), gallbladder remnant cholecystitis (OR: 0.21, p = 0.09) or need for completion cholecystectomy (RD: 0.01, p = 0.59) between two groups. CONCLUSIONS: Fenestrating STC is associated with a higher risk of bile leak than the reconstructing technique. This issue can be mitigated by routine use of drains, delayed drain removal, and in selected cases endoscopic therapy. We encourage the fenestrating approach considering trends in improved short- and long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom. Electronic address: shahin_hajibandeh@yahoo.com.
- Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff, United Kingdom.
- Division of Hepatobiliary and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
- Hepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Zitieren
APA
Hajibandeh, S., Hajibandeh, S., Parente, A., Laing, R. W., Bartlett, D., Athwal, T. S., & Sutcliffe, R. P. (2024). Meta-analysis of fenestrating versus reconstituting subtotal cholecystectomy in the management of difficult gallbladder. HPB, 26(1), 8-20. https://doi.org/10.1016/j.hpb.2023.09.005
Vancouver
Hajibandeh S, Hajibandeh S, Parente A, Laing RW, Bartlett D, Athwal TS, et al. Meta-analysis of fenestrating versus reconstituting subtotal cholecystectomy in the management of difficult gallbladder. HPB. 2024;26(1):8-20. doi:10.1016/j.hpb.2023.09.005
BibTeX
@article{Hajibandeh2024,
author = {Hajibandeh, Shahin and Hajibandeh, Shahab and Parente, Alessandro and Laing, Richard W and Bartlett, David and Athwal, Tejinderjit S and Sutcliffe, Robert P},
title = {Meta-analysis of fenestrating versus reconstituting subtotal cholecystectomy in the management of difficult gallbladder},
journal = {HPB},
year = {2024},
volume = {26},
number = {1},
pages = {8--20},
doi = {10.1016/j.hpb.2023.09.005}
}
EUVIMED